Login / Signup

S-15 in combination of Akt inhibitor promotes the expansion of CD45RA-CCR7+ tumor infiltrating lymphocytes with high cytotoxic potential and downregulating PD-1+Tim-3+ cells as well as regulatory T cells.

Ben-Ling XuLong YuanGuangyu ChenTiepeng LiJinxue ZhouChengjuan ZhangPeng QinMusleh M MuthanaShengdian WangXuexiang DuQuanli Gao
Published in: Cancer cell international (2019)
Our study elucidates that IL-2/S-15/Akti expanded Tils and represent a viable source for the cellular therapy for patients with hepatocellular cancer.
Keyphrases